Ning Zhang

机构：Fudan University Shanghai Cancer Center, First People's Hospital of Foshan, Nanjing Brain Hospital, Anhui Provincial Hospital · ORCID：0000-0003-1867-5930

发表论文 58 篇 · 总被引 745 次 · h-index 15

代表论文

• Adjuvant PD-1 Blockade With Camrelizumab for Nasopharyngeal Carcinoma (2025 · JAMA · 被引 66)
• Matrisome gene-based subclassification of patients with liver fibrosis identifies clinical and molecular heterogeneities (2023 · Hepatology · 被引 28)
• Detection of α‐Synuclein in Oral Mucosa by Seed Amplification Assay in Synucleinopathies and Isolated REM Sleep Behavior Disorder (2024 · Movement Disorders · 被引 25)
• Targeting thrombospondin-2 retards liver fibrosis by inhibiting TLR4-FAK/TGF-β signaling (2024 · JHEP Reports · 被引 16)
• Tyrosine Kinase Inhibitors Plus Anti-PD-1 Antibodies with Hepatic Arterial Infusion Chemotherapy or Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma (2023 · Journal of Hepatocellular Carcinoma · 被引 16)
• Hepatectomy After Conversion Therapy with Hepatic Arterial Infusion Chemotherapy, Tyrosine Kinase Inhibitors and Anti-PD-1 Antibodies for Initially Unresectable Hepatocellular Carcinoma (2023 · Journal of Hepatocellular Carcinoma · 被引 14)